[LGND] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -300.09%
YoY- -148.03%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 18,418 10,608 9,580 5,742 7,463 5,838 7,594 15.90%
PBT 22,292 1,241 3,804 -3,728 -773 335 -4,476 -
Tax 265 -47 110 338 141 625 -4,476 -
NP 23,564 1,592 6,091 -2,267 -914 -283 -1,668 -
Tax Rate -1.19% 3.79% -2.89% - - -186.57% - -
Total Cost -5,146 9,016 3,489 8,009 8,377 6,121 9,262 -
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 127.94 15.01 63.58 -39.48 -12.25 -4.85 -21.96 -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
EPS 1.19 0.08 0.30 -0.11 -0.05 -0.01 -0.09 -
EPS Diluted 1.11 0.07 0.30 -0.11 -0.05 -0.01 -0.09 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.